Novartis AG (NVSEF) stock
NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS
$146.46+2.56 (+1.78%)
Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –
Novartis price to free cash flow
Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.
Novartis's price to free cash flow was 17.7× on Nov 3, 2026, against 16.3× a year earlier. Over the last 5 years it ranged from 12.3× to 19.8×, with a median of 16.1×.
Price to Free Cash Flow at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 3, 2026 | 17.7× | +0.4 |
| 2025 | Dec 31, 2025 | 17.3× | +2.1 |
| 2024 | Dec 31, 2024 | 15.2× | −1.5 |
| 2023 | Dec 29, 2023 | 16.7× | +2.0 |
| 2022 | Dec 30, 2022 | 14.6× | −1.6 |
| 2021 | Dec 31, 2021 | 16.2× | −1.7 |
| 2020 | Dec 31, 2020 | 17.9× | +0.8 |
| 2019 | Dec 31, 2019 | 17.1× | −0.6 |
| 2018 | Dec 31, 2018 | 17.6× | −3.1 |
| 2017 | Dec 29, 2017 | 20.7× | +2.6 |
| 2016 | Dec 30, 2016 | 18.1× | – |
See a number that looks wrong?